Cypress Capital Group’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,988
| Closed | -$363K | – | 302 |
|
|
2023
Q2 | $363K | Buy |
2,988
+23
| +0.8% | +$2.8K | 0.05% | 241 |
|
|
2023
Q1 | $455K | Buy |
2,965
+184
| +7% | +$28.3K | 0.07% | 216 |
|
|
2022
Q4 | $500K | Buy |
2,781
+612
| +28% | +$110K | 0.08% | 213 |
|
|
2022
Q3 | $257K | Sell |
2,169
-47
| -2% | -$5.57K | 0.04% | 251 |
|
|
2022
Q2 | $317K | Buy |
2,216
+463
| +26% | +$66.2K | 0.05% | 242 |
|
|
2022
Q1 | $304K | Buy |
1,753
+732
| +72% | +$127K | 0.04% | 259 |
|
|
2021
Q4 | $259K | Sell |
1,021
-1,010
| -50% | -$256K | 0.03% | 271 |
|
|
2021
Q3 | $782K | Buy |
2,031
+411
| +25% | +$158K | 0.11% | 168 |
|
|
2021
Q2 | $380K | Sell |
1,620
-102
| -6% | -$23.9K | 0.05% | 232 |
|
|
2021
Q1 | $226K | Sell |
1,722
-830
| -33% | -$109K | 0.03% | 260 |
|
|
2020
Q4 | $267K | Buy |
+2,552
| New | +$267K | 0.04% | 237 |
|